Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antimetabolites”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Post-approval studies (Phase 4)Study completedNCT02177071
What this trial is testing

A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy

Who this might be right for
Crohn's Disease
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 211
Testing effectiveness (Phase 2)Study completedNCT01808248
What this trial is testing

Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3

Who this might be right for
Hepatitis C
Gilead Sciences 47
Large-scale testing (Phase 3)Study completedNCT01851330
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 647
Testing effectiveness (Phase 2)Ended earlyNCT00838578
What this trial is testing

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Kyowa Kirin Co., Ltd. 65
Large-scale testing (Phase 3)UnknownNCT01917279
What this trial is testing

Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC

Who this might be right for
Breast NeoplasmsNeoplasms by SiteNeoplasm Metastasis+2 more
Binghe Xu 280
Large-scale testing (Phase 3)Study completedNCT01838590
What this trial is testing

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 103
Testing effectiveness (Phase 2)Ended earlyNCT04365101
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

Who this might be right for
CoronavirusCoronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2+17 more
Celularity Incorporated 7
Large-scale testing (Phase 3)Study completedNCT01964430
What this trial is testing

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

Who this might be right for
Pancreatic NeoplasmsDigestive System NeoplasmsNeoplasms by Site+7 more
Celgene 866
Large-scale testing (Phase 3)Study completedNCT06745856
What this trial is testing

Intraoperative 5-fluorouracil Augmentation of Trabeculectomy

Who this might be right for
GlaucomaPrimary Open Angle Glaucoma
Moorfields Eye Hospital NHS Foundation Trust 368
Early research (Phase 1)Study completedNCT02171221
What this trial is testing

Phase I Study of Oral DFP-11207 in Solid Tumors

Who this might be right for
Solid TumorsCancer
Delta-Fly Pharma, Inc. 23
Post-approval studies (Phase 4)UnknownNCT01325818
What this trial is testing

The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris

Who this might be right for
Coronary DiseaseHypercholesterolemia
Yokohama City University Medical Center 150
Testing effectiveness (Phase 2)Study completedNCT00001498
What this trial is testing

A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
National Cancer Institute (NCI) 55
Early research (Phase 1)Ended earlyNCT04310592
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute+17 more
Celularity Incorporated 27
Large-scale testing (Phase 3)UnknownNCT03101800
What this trial is testing

Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis

Who this might be right for
Colitis, UlcerativeColitis Ulcerative Exacerbation
Hvidovre University Hospital 84